Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Down 95.3% in January

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 1,400 shares, a decrease of 95.3% from the January 15th total of 29,500 shares. Based on an average daily trading volume, of 107,000 shares, the days-to-cover ratio is presently 0.0 days.

Conduit Pharmaceuticals Trading Up 20.9 %

NASDAQ CDTTW opened at $0.02 on Thursday. Conduit Pharmaceuticals has a 1 year low of $0.01 and a 1 year high of $0.15. The company has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.01.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.